Medisys Research

The MediSys Health Network and its member hospitals, Flushing Hospital Medical Center and Jamaica Hospital Medical Center, are teaching facilities that pride themselves on their dedication to continuing education and research. On this website you will find a comprehensive catalog of the many forms of research we do, including residency poster presentations, performance improvement projects, and links to nationally published works.  We feel this collection demonstrates our commitment to clinical and non-clinical research with the goal of improving patient care.

Browse Library

Published WorkPoster PresentationsPerformance ImprovementClinical TrialsAdvanced Search

Most Recent Uploads

Top rated water picks

Saturday 25th March 2023
A Case of Necrotizing Fasciitis Mimicking a Burn in an Elderly Patient
Wednesday 22nd March 2023
Closed-Loop Gastric Outlet Obstruction Secondary to Duodenal Ulcer in a Patient With Esophageal Stricture
Tuesday 7th March 2023
An Infected, Noncoronary, Bare Metal Stent Presenting as a Right Groin Abscess
Tuesday 20th December 2022
The UCI EyeMobile Preschool Vision Screening Program: Refractive Error and Amblyopia Results from the 2019–2020 School Year
Tuesday 11th October 2022
Calcification in Thoracic Splenosis

Poster Presentations

Saturday 5th November 2022
Chasing the Dragon
Saturday 5th November 2022
Chasing the Dragon
Friday 21st October 2022
Steroid use in management of viral meningoencephalitis requiring ICU level care
Friday 21st October 2022
Oh the Nerve: A Paralyzing Trickster in the Immune Deficient Patient
Friday 21st October 2022
When a mechanical problem doesn’t have a mechanical solution: managing a critically ill patient with occupying intrathoracic lesion, it’s about timing

Performance Improvement

Clinical Trials

Thursday 5th May 2022
A randomized, controlled, multi-center, open-label trial comparing a hospital, post-discharge care pathway involving aggressive LDL-C management that includes inclisiran with usual care versus usual care alone in patients with a recent coronary syndrome
Tuesday 11th January 2022
Phase 1B/2A, randomized, double-blind, placebo-controlled, multiple ascending dose escalation study of the safety, tolerability, and efficacy of intravenous AP-SA02 as an adjunct to best available therapy alone for the treatment of adults with bacteremia due to Staphylococcus aureus.
Friday 14th August 2020
Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID)
Tuesday 5th May 2020
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19.
Friday 1st May 2020
A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia (MARIPOSA)